Identifying diabetics in Medicare claims and survey data: implications for health services research by Sakshaug, Joseph W et al.
RESEARCH ARTICLE Open Access
Identifying diabetics in Medicare claims and
survey data: implications for health services
research
Joseph W Sakshaug1,2*, David R Weir1 and Lauren H Nicholas3
Abstract
Background: Diabetes health services research often utilizes secondary data sources, including survey self-report
and Medicare claims, to identify and study the diabetic population, but disagreement exists between these two
data sources. We assessed agreement between the Chronic Condition Warehouse diabetes algorithm for Medicare
claims and self-report measures of diabetes. Differences in healthcare utilization outcomes under each diabetes
definition were also explored.
Methods: Claims data from the Medicare Beneficiary Annual Summary File were linked to survey and blood
data collected from the 2006 Health and Retirement Study. A Hemoglobin A1c reading, collected on 2,028
respondents, was used to reconcile discrepancies between the self-report and Medicare claims measures of diabetes.
T-tests were used to assess differences in healthcare utilization outcomes for each diabetes measure.
Results: The Chronic Condition Warehouse (CCW) algorithm yielded a higher rate of diabetes than respondent
self-reports (27.3 vs. 21.2, p < 0.05). A1c levels of discordant claims-based diabetics suggest that these patients
are not diabetic, however, they have high rates of healthcare spending and utilization similar to diabetics.
Conclusions: Concordance between A1c and self-reports was higher than for A1c and the CCW algorithm. Accuracy
of self-reports was superior to the CCW algorithm. False positives in the claims data have similar utilization profiles
to diabetics, suggesting minimal bias in some types of claims-based analyses, though researchers should consider
sensitivity analysis across definitions for health services research.
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Background
Diabetes has become one of the most common and expen-
sive medical conditions amongst older adults. Nearly 25%
of all adults ages 60 and older have diabetes in the United
States [1] and this group accounts for over half of the more
than $100 billion in healthcare expenditures attributable to
this disease [2]. Reducing the disease and economic burden
of diabetes has been a long-standing goal in health policy.
Carefully designed analyses of secondary datasets, in-
cluding Medicare claims data, can contribute to diabetes
health services research. The strength of this design is
critically dependent on being able to identify diabetic pa-
tients in datasets. Utilization-based algorithms are fre-
quently used to identify chronic disease cohorts in
national Medicare data and other administrative datasets.
However, concordance between disease status assessed by
these algorithms and patient self-reports can be low, rais-
ing concern about the bias associated with research de-
signs relying on non-clinical data [3,4].
A diabetes diagnosis requires clinical measures of
Hemoglobin A1c (the gold standard since 2010), a measure
of blood sugar control over the past 60–90 days, or fasting
blood sugar [5]. However, obtaining clinical measures of
diabetes status for health services research is rare, and most
researchers rely on more subjective measures, such as self-
reports or claims-based diagnoses to identify the diabetic
population. Both measures have strengths and limitations.
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Self-reports are commonly used to assess diabetes
prevalence in survey data when biological measures are
unavailable [6-9]. Self-reports are believed to underesti-
mate diabetes prevalence because they depend on a pa-
tient seeing a doctor to receive a clinical diagnosis and
correctly reporting when asked. The standard approach
in surveys with biomarkers is to take all self-reports as
true cases and add in the people who self-report “no”
but test above the diagnostic threshold. The National
Health and Nutrition Examination Survey (NHANES) is
the most common data source used for studying the
population of undiagnosed diabetics. The latest pub-
lished NHANES estimates for the 65 and older popula-
tion for years 2003–2006 indicate a diabetes rate of
21.1% based on the sum of self-reported diabetics (17.7%)
and self-reported non-diabetics with an A1c reading
greater than or equal to 6.5 (3.5%) [10].
Claims-based diagnoses may be obtained from patient
billing records, hospital discharge abstracts, and phys-
ician data and are usually based on algorithms that may
or may not match actual diagnoses found in medical re-
cords [11]. The Center for Medicare and Medicaid
Services’ Chronic Condition Warehouse (CCW) algorithm
is the primary diabetes algorithm used in Medicare
claims-based research as it is included in their research
files and many users are likely to implement it given in-
clusion in the Beneficiary Annual Summary File. The
CCW algorithm defines a diabetic as someone who has
had at least one inpatient, skilled nursing or home health
visit or at least two outpatient visits with a diabetes-
related ICD-9 code during a two year period [12]. This
definition was observed to be adequately sensitive
(≥70%) and reliable (kappa ≥ 0.80) [13]. Other studies of
administrative claims-based measures of diabetes status
have yielded varying sensitivities ranging from 64% to
87% when validated against different benchmarks, in-
cluding laboratory data, medical records, and self-
reports [4,14-16].
Investigating the quality of survey self-report and claims-
based diabetes measures is important because data users
rely on these measures in health services research to
produce population-based estimates of the diabetes
population. These estimates often have important pol-
icy implications and any inaccuracies can lead to incor-
rect inferences. For example, overestimation of the
diabetes population may lead to misleading conclu-
sions about the quality of diabetes care as the false
positives may be seen as not receiving adequate amounts
of care. Conversely, underestimation of the diabetes popu-
lation may lead to conclusions that understate the preva-
lence of the disease and the economic burden of the
disease.
This paper provides some insight as to the accuracy of
self-report and CCW claims-based diabetes measures
and their implications for health services research. In it,
we use nationally representative survey data linked to
Medicare claims and measured Hemoglobin A1c levels
from an in-person blood draw to compare the accuracy
of the self-report and CCW measures relative to the A1c
reading. Furthermore, we examine discrepancies be-
tween the two measures and compare commonly used
healthcare utilization outcomes across each of the dia-
betes definitions.
Methods
We utilize the 2006 wave of the Health and Retirement
Study (HRS) [17]. The HRS is a nationally representative
longitudinal study of Americans over the age of 50. In
2006, HRS began collecting several physical measure-
ments, including biologic specimens: saliva and dried
blood spots. Here we focus on the collection of blood
spots and measured Hemoglobin A1c to validate and
understand discrepancies in self-reported and claims-
based diabetes status, which was obtained for 83 percent
of the biomarker subsample who consented to the blood
draw.
Medicare-eligible HRS respondents were asked for
permission to link their Medicare records from the
Centers for Medicare and Medicaid Services (CMS). HRS
data and records from the 2006 Medicare Beneficiary
Table 1 Prevalence of Diabetes amongst Adults ages 65 and older in Three National Samples
NHANES Linked HRS/A1c Linked HRS/Medicare Linked HRS/Medicare/A1c
Self-report 19.1% (16.6-21.6) 21.3% (19.8-22.8) 21.7% (20.4-23.0) 21.2% (19.2-23.2)
Hemoglobin A1c≥ 6.5 12.2% (10.1-14.3) 13.0% (11.8-14.1) – 12.6% (10.7-14.4)
Undiagnosed 3.8% (1.8-5.7) 4.2% (3.3-5.2) – 4.4% (3.2-5.6)
Self-report + undiagnosed 22.9% 25.5% – 25.6%
Medicare claims – – 28.7% (27.1-30.2) 27.3% (25.3-29.2)
Sample size 1,066 3,817 6,101 2,028
Parenthetical entries are 95% confidence intervals.
Undiagnosed diabetes refers to the percentage of cases who self-reported not ever receiving a diabetes diagnosis but met the clinical threshold for
diabetes (Ha1c ≥ 6.5).
Sources: 2006 Health and Retirement Study (HRS); 2006 Medicare Beneficiary Annual Summary File; 2005–2006 National Health and Nutrition Examination
Survey (NHANES).
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Annual Summary Files were linked for 88 percent of re-
spondents who consented to the linkage. Consent rates
were higher for younger, wealthier, Hispanic, and non-
white respondents. Diabetes prevalence is higher amongst
minorities and the younger-old [2], suggesting that the
self-selected subsample represents persons who are more
likely to be diabetic.
Three measures of diabetes status were utilized: survey
self-reports (“Has a doctor ever told you that you have
diabetes or high blood sugar?”), indication of diabetes
based on the Chronic Condition Warehouse (CCW) algo-
rithm, and a Hemoglobin A1c score of 6.5 or higher [5].
Four healthcare utilization outcomes were extracted
from the Medicare claims and used to assess differences
between the diabetes definitions. The first three out-
comes (total Medicare reimbursement, number of office
visits, and number of hospitalizations in 2006) relate to
general healthcare usage. The last outcome, the number
of A1c tests ordered between years 2002–2005, is used
as an indicator of quality of diabetes care, a commonly
used measure in quality of care studies [18-21].
We restrict the sample to persons aged 65 years and
older who were Medicare-eligible at the time of inter-
view (n = 11,354). The sample was further restricted to
individuals randomly selected for biomarker collection
(n = 5,784), of which 3,820 completed the blood draw
and received a valid A1c score. Of these cases, Medicare
records were linked to 3,389 respondents. Beneficiaries
who were not continuously enrolled in fee-for-service
Medicare were excluded (n = 1,185) along with potential
users of Veterans Affairs (VA) services to ensure that
all health care utilization was reflected in the claims
(n = 176). The resulting analytic sample consisted of 2,028
respondents.
Concordance between the self-report and claims data
was assessed using t-tests and two-way tables. Mean A1c
levels and utilization outcomes are reported for the con-
cordant and discordant cases. All analyses were per-
formed using appropriate survey procedures in SAS
Table 3 Percent of Medicare beneficiaries aged 65 and older,
by Discordant (Claims) and Concordant Diabetes
Classification Group and characteristics
Claims-based
diabetics
(Discordant)
Concordant diabetics
(Self-report and claims)
Age
65–74 34.0 (3.7; 65)* 50.8 (2.7; 230)*
75–84 48.3 (4.3; 72) 39.5 (2.5; 148)
85+ 17.8 (3.3; 25)* 9.7 (1.7; 28)*
Gender
Male 39.5 (4.2; 62) 45.1 (2.1; 184)
Ethnicity
Hispanic 4.4 (1.7; 9) 7.0 (1.8; 34)
Race
Non-White 13.8 (2.8; 31) 10.2 (1.5; 58)
HH income
(quartiles of SR &
Claims group)
Q1 ($15,827 or less) 30.1 (3.8; 50) 26.9 (2.7; 102)
Q2 ($15,828-$30,576) 21.7 (4.0; 33) 24.4 (2.3; 100)
Q3 ($30,577-$49,438) 22.0 (4.5; 37) 23.7 (1.8; 102);
Q4 ($49,439 or more) 26.3 (3.1; 42) 25.0 (2.6; 102)
Health rating 29.9 (3.2; 52)* 21.8 (2.6; 91)*
Excellent/VG 36.7 (3.4; 59) 35.5 (2.7; 144)
Good 33.5 (3.8; 51) 42.8 (4.1; 171)
Fair/Poor
Moderate activity 45.8 (3.5; 72) 44.4 (2.5; 175)
Hardly ever/never
Number of diseases 14.8 (2.7; 22) 9.8 (1.8; 40)
0 41.4 (3.4; 71) 37.5 (2.2; 163)
1 24.5 (3.9; 42) 31.5 (1.7; 124)
2 19.3 (3.6; 27) 21.2 (2.4; 79)
3+
Self-Reported Memory Rating
Excellent/Very good 16.7 (2.8; 26) 20.3 (2.0; 82)
Good 43.4 (3.7; 71) 44.2 (2.2; 173)
Fair/Poor 39.9 (3.1; 65) 35.5 (3.0; 151)
Cognitive Functioning
(TICS Score)
0–8 23.1 (4.3; 39) 18.1 (1.9; 68)
9 21.4 (3.7; 35) 27.4 (2.2; 111)
10 55.5 (5.1; 88) 54.6 (2.6; 227)
Total number of flagged diabetics 162 406
Notes: Standard errors and sample sizes are in parentheses.
Column percentages may not always add to 100 due to rounding error.
*Difference between self-report estimate and claims estimate is statistically
significant p<0.05.
Source: 2006 Health and Retirement Study; 2006 Medicare Beneficiary Annual
Summary File.
Table 2 Cross-classification of self-report and claims-based
diabetes status
Medicare claims (%)
Not diabetic Diabetic
Self-report (%)
Not diabetic 71.1 (1426) 7.7 (162)
Diabetic 1.6 (34) 19.5 (406)
Chi-square test statistic: 737.7; p < 0.05.
Cohen’s Kappa statistic: 0.74.
Parenthetical entries are sample sizes.
Claims-based diabetics are defined as those who have ever triggered the CCW
definition for diabetes.
Sources: 2006 Health and Retirement Study (HRS); 2006 Medicare Beneficiary
Annual Summary File.
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9.1.3 inside a secure data enclave at the Institute for
Social Research in Ann Arbor, Michigan. This study was
exempt from Institutional Review Board oversight.
Results
First, to assess the comparability of our analytic sample
we compare diabetes estimates from the linked HRS-
Medicare-A1c sample with those from three national
samples: the 2005–2006 National Health and Nutrition
Examination Survey (NHANES), the linked HRS-A1c
only sample, and the linked HRS-Medicare only sample.
All samples are restricted to the Medicare-eligible popu-
lation aged 65 and older. Table 1 shows that the percent-
age of self-reported diabetics (Table 1) (21.1; 95% CI:
19.2-23.2), clinical diabetics with A1c reading ≥ 6.5 (12.6;
10.7-14.4), and undiagnosed diabetics (4.4; 95% CI: 3.2-
5.6) in the linked HRS-Medicare-A1c sample are sta-
tistically comparable to the corresponding estimates
obtained from the other three samples, suggesting
consistency across the sources and minimal bias in
using the linked HRS-Medicare-A1c sample.
The CCW claims-based algorithm yields a significantly
higher percentage of diabetes compared to self-reports
(Claims: 27.3; SRs: 21.2; p < 0.05). However, the overall
percentage of diabetes (based on the sum of self-reported
and undiagnosed diabetics) obtained from the survey data
(25.6) is statistically indiscernible from the claims-based
estimate (27.3; 95% CI: 25.3-29.2).
The next analysis examines the two-way agreement be-
tween self-report and the claims-based diabetes definitions
(Table 2). About 19.5 percent (or n = 406) of respondents
are classified as diabetic based on both self-report and
claims data and 71.1 percent (or n = 1,426) are classified
as non-diabetics in both data sources. The remaining 9.3%
of the sample (n = 196) yield a conflicting a result between
the two measures. Most of the discordant cases (82.7 per-
cent; n = 162, 7.7 percent of total sample) are flagged as
diabetic in the claims data. Discordant claims-based dia-
betics tend to be older and self-report better health status
compared to concordant diabetics (Table 3).
Clinical classifications based on A1c readings are
shown in Table 4. Not surprisingly, concordant diabetics
(CDs) and concordant non-diabetics (CNDs), respect-
ively, yield the highest and lowest percentage of clinical
diabetes (A1c ≥ 6.5), respectively (CDs: 45.7; CNDs: 3.5)
among the four possible agreement groups. Among the
discordant cases, self-reported diabetics yield a signifi-
cantly higher mean A1c reading (6.32 vs. 5.86), a higher
percentage of clinical diabetes (30.5 vs. 12.4), and a
lower percentage of A1c readings less than 6.0 (42.8 vs.
63.6) relative to the CCW-based diabetics (all compari-
sons yield p-value < 0.05).
Of the 4.4% of the undiagnosed sample who were clas-
sified as diabetic based on having an A1c score ≥ 6.5,
only 29.9% (95% CI: 18.l-39.9) of them were reported as
being diabetic in the claims data. Thus, the claims data
Table 5 Hemoglobin A1c levels and utilization outcomes by self-report and chronic condition warehouse
diabetes status
Self-report, yes; Claims, yes Self-report, yes; Claims, no Self-report, no; Claims, yes Self-report, no; Claims, no
Healthcare Utilization
(2006)
A1c < 6.5 A1c > 6.5 A1c < 6.5 A1c > 6.5 A1c < 6.5 A1c > 6.5 A1c < 6.5 A1c > 6.5
Total reimbursement 9400.7
(1079.6)
8770.8
(1030.8)
3275.4
(1493.9)
11823.0
(8682.9)
9383.8
(1406.3)
8613.2
(2734.9)
4731.2
(320.9)
3507.0
(803.4)
Total hospitalizations 0.39 (0.05) 0.36 (0.06) 0.19 (0.10) 0.32 (0.17) 0.34 (0.06) 0.47 (0.14) 0.23 (0.02) 0.15 (0.07)
Total office visits 10.29 (0.71) 10.01 (0.52) 5.22 (1.53) 1.59 (0.41) 10.93 (0.90) 10.27 (1.86) 6.62 (0.23) 6.27 (0.73)
Total A1c tests
(2002–2005)
4.67 (0.29) 4.86 (0.42) 0.48 (0.26) 0.77 (0.77) 0.78 (0.13) 2.16 (0.54) 0.09 (0.01) 0.26 (0.15)
Sample size 225 181 21 13 141 21 1377 49
Parenthetical entries are standard errors.
Source: 2006 Health and Retirement Study; 2006 Medicare Beneficiary Annual Summary File.
Table 4 Hemoglobin A1c estimates by self-report and chronic condition warehouse diabetes status
Clinical measures Self-report, yes; Claims, yes Self-report, yes; Claims, no Self-report, no; Claims, yes Self-report, no; Claims, no
Hemoglobin A1c (mean) 6.60 (0.05) 6.32 (0.03) 5.86 (0.04) 5.64 (0.02)
Hemoglobin A1c≥ 6.5 (%) 45.7 (2.4) 30.5 (0.5) 12.4 (2.2) 3.5 (0.6)
Hemoglobin A1c < 6.0 (%) 24.8 (2.5) 42.8 (2.9) 63.6 (2.6) 80.8 (1.4)
Sample size 406 34 162 1426
Parenthetical entries are standard errors.
Source: 2006 Health and Retirement Study; 2006 Medicare Beneficiary Annual Summary File.
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do not differ from self-report primarily because of better
classification of the undiagnosed cases.
The results are suggestive that self-reports produce a
more accurate indication of a diabetes diagnosis (based
on clinical data) relative to the CCW algorithm. Hence,
an important question to ask is whether healthcare
utilization profiles are distorted by using the CCW-
algorithm to identify the diabetic population.
Table 5 shows that the healthcare utilization outcomes
among discordant claims-based diabetics are generally
similar to that of concordant diabetics regardless of A1c
levels. However, the number of A1c tests received was
markedly lower for the discordant claims-based diabetics
than for the concordant diabetics (p-value < 0.05). This
pattern of use suggests that discordant claims-based dia-
betics do not receive diabetes-related care at the same
rate as concordant diabetics but do receive an overall
level of health services and have expenditures similar to di-
abetics. Regression-adjusted results (controlling for demo-
graphic characteristics) yielded the same conclusions.
Discussion and conclusions
In this study nationally-representative data linked with
biomarker and Medicare claims were used to study the
agreement between self-report and claims-based measures
of diabetes. The claims-based CCW algorithm yielded a
significantly higher rate of diabetics compared to self-
reports. The biomarker data suggested that the higher rate
of diabetics in the claims was due to false positives. False
positives tended to be associated with high users of Medi-
care services with provider utilization profiles similar to
those of concordant diabetics. Higher rates of diabetes
prevalence in claims data may reflect intensive monitoring
of pre-diabetic patients with elevated levels of other car-
diovascular risk factors.
Our results raise potential concerns about attempts to
use the current CCW diabetes indicator to identify dia-
betics in claims data for the purpose of assessing quality
of care. Regions or accountable care organizations with
high proportions of false positives may correctly fail to
provide ongoing diabetes maintenance care to these pa-
tients, and thus appear to provide lower quality of care
to diabetic patients (e.g., lower A1c testing).
Our findings should be interpreted in the context of
the following considerations. This study relies on a sin-
gle measure of Hemoglobin A1c rather than repeated
measures of fasting plasma glucose or glucose tolerance
test results to validate the self-report and claims-based
measures of diabetes. Furthermore, people with diabetes
who are controlled may have an A1c score below 6.5.
We did not have access to Part D claims, though infor-
mation about use of insulin or oral diabetes medications
would have been another way to identify patients being
treated for diabetes. However, the tradeoff would be a
less representative sample as not all Medicare beneficiar-
ies are in a stand-alone Part D plan that would have re-
search data. Nevertheless, efforts to refine and validate
claims-based algorithms with medication information
may help to improve the use of these measures for
health services research.
Diabetes is an important and costly chronic condition.
Researchers interested in studying treatment and health-
care utilization outcomes associated with diabetes face a
variety of measures to identify this subgroup. We find
strengths and weaknesses of using self-reports and
claims-based measures to identify the diabetic popula-
tion. For researchers fortunate enough to have both
measures available then the choice of which measure to
use should be driven by the goals of the analysis (e.g.,
estimating prevalence, assessing quality of care, profiling
aggregate levels of utilization) and sensitivity of the re-
sults obtained from both measures. However, if the
CCW algorithm is the only measure available, then re-
sults should be interpreted with caution, particularly if
those results pertain to diabetes prevalence and quality
of care analyses.
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